| View |
|
DR-XY49087
|
Ivabradine (as hydrochloride)
|
Abrin
|
7.5 mg
|
Film-Coated Tablet
|
Other Cardiac Preparation.
|
The Searle Company Limited
|
Pakistan
|
Initial (Reapplication)
|
21 May 2024
|
21 May 2029
|
| View |
|
DR-XY49088
|
Apixaban
|
Apiban 5
|
5 mg
|
Film-Coated Tablet
|
Antithrombotic Agent
|
MSN Laboratories Private Limited
|
India
|
Initial
|
22 May 2024
|
22 May 2029
|
| View |
|
DR-XY49089
|
Trimetazidine dihydrochloride
|
Trimet PR-80
|
80 mg
|
Prolonged-Release Capsule
|
Anti-angina (Cardiac Preparation)
|
Globela Pharma Private Limited
|
India
|
Monitored Release (MR)
|
22 May 2024
|
22 May 2029
|
| View |
|
DR-XY49090
|
Capecitabine
|
Emcap 500
|
500 mg
|
Film-Coated Tablet
|
Antineoplastic
|
MSN Laboratories Private Limited (Formulations Division)
|
India
|
Initial (Reapplication)
|
31 May 2024
|
31 May 2029
|
| View |
|
DR-XY49091
|
Ceftriaxone (as sodium)
|
Zeftinox
|
1 g
|
Powder for Solution for Injection (IV/IM)
|
Third-Generation Cephalosporin
|
Chengdu Brilliant Pharmaceutical Co., Ltd.
|
China
|
Initial
|
23 May 2024
|
23 May 2029
|
| View |
|
DR-XY49092
|
Tranexamic Acid
|
Khrizemic
|
100 mg/mL (500 mg/5 mL)
|
Solution for Injection (I.V.)
|
Antifibrinolytic
|
Skymap Healthcare Pvt. Ltd.
|
India
|
Initial
|
24 May 2024
|
24 May 2029
|
| View |
|
DR-XY49094
|
Ceftriaxone
|
Luotriaxone
|
500 mg
|
Powder for Solution for Injection (IM/IV)/
Infusion
|
Third-Generation Cephalosporin
|
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
|
China
|
Initial
|
27 May 2024
|
27 May 2029
|
| View |
|
DR-XY49095
|
Ceftriaxone (as sodium)
|
Luoriaxon
|
1 g
|
Powder for Solution for Injection (IM/IV)/Infusion
|
Third-Generation Cephalosporin
|
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
|
China
|
Initial
|
27 May 2024
|
27 May 2029
|
| View |
|
DR-XY49096
|
Loperamide + Simethicone
|
Imodium Complete Relief
|
2 mg/125 mg
|
Tablet
|
Antipropulsive
|
JNTL Consumer Health (France) S.A.S.
|
France
|
Initial
|
28 May 2024
|
28 May 2029
|
| View |
|
DR-XY49097
|
Cetirizine hydrochloride
|
Benadryl One
|
10 mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine Derivative)
|
Janssen-Cilag S.P.A
|
Italy
|
Initial
|
29 May 2024
|
29 May 2029
|
| View |
|
DR-XY49098
|
Cetirizine hydrochloride
|
Benadryl One
|
10 mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine Derivative)
|
Janssen-Cilag S.P.A.
|
Italy
|
Initial
|
29 May 2024
|
29 May 2029
|
| View |
|
DR-XY49099
|
Losartan Potassium + Hydrochlorothiazide
|
Altrazide
|
50 mg/12.5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB) and Diuretic
|
CB Healthcare
|
India
|
Initial
|
29 May 2024
|
29 May 2029
|
| View |
|
DR-XY49100
|
Flucloxacillin
|
Khrizfloxin
|
500 mg
|
Capsule
|
Antibacterial (Beta-Lactamase Resistant Penicillin)
|
Sparsh Bio-Tech Pvt. Ltd.
|
India
|
Initial
|
31 May 2024
|
31 May 2029
|
| View |
|
DR-XY49101
`
|
Silver Sulfadiazine
|
Vexsilva
|
10 mg/g (1% w/w)
|
Cream
|
Chemotherapeutic for Topical Use (Sulfonamide)
|
Yash Pharmaceuticals
|
India
|
Initial
|
31 May 2024
|
31 May 2029
|
| View |
|
DR-XY49102
|
Tadalafil
|
Torfil 5
|
5 mg
|
Film-Coated Tablet
|
Drug Used in Erectile Dysfunction
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial
|
03 June 2024
|
03 June 2029
|
| View |
|
DR-XY49103
|
Telmisartan + Hydrochlorothiazide
|
Telarb Plus
|
80 mg/ 25 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) + Diuretic,
|
Inventia Healthcare Limited.
|
India
|
Initial
|
03 June 2024
|
03 June 2029
|
| View |
|
DR-XY49104
|
Telmisartan + Hydrochlorothiazide
|
Telarb Plus
|
40 mg/ 12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) + Diuretic
|
Inventia Healthcare Limited
|
India
|
Initial
|
03 June 2024
|
03 June 2029
|
| View |
|
DR-XY49105
|
Telmisartan + Hydrochlorothiazide
|
Telarb Plus
|
80 mg/ 12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) + Diuretic
|
Inventia Healthcare Limited
|
India
|
Initial
|
03 June 2024
|
03 June 2029
|
| View |
|
DR-XY49106
|
Levetiracetam
|
Levetroy
|
100 mg/mL
|
Concentrate Solution for Injection
(IV Infusion)
|
Antiepileptic
|
Troikaa Pharmaceuticals Limited
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DR-XY49107
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Aezitam 4.5
|
4 g/ 500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin/ Beta-Lactamase Inhibitor)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
18 June 2024
|
18 June 2029
|